English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Chronic Δ9-tetrahydrocannabinol (Δ9-THC) administration produces tolerance to cannabinoid effects, but alterations in signal transduction that mediate these changes are not yet known. The present study uses in vitro autoradiography of agonist-stimulated [35S]GTPγS binding to localize cannabinoid receptor-activated G-proteins after chronic Δ9-THC treatment. Cannabinoid (WIN 55212-2)-stimulated [35S]GTPγS binding was performed in brain sections from rats treated chronically with 10 mg/kg Δ9-THC for 21 d. Control animals received saline or an acute injection of Δ9-THC. Acute Δ9-THC treatment had no effect on basal or WIN 55212-2-stimulated [35S]GTPγS binding. After chronic Δ9-THC treatment, net WIN 55212-2-stimulated [35S]GTPγS binding was reduced significantly (up to 70%) in most brain regions, including the hippocampus, caudate-putamen, perirhinal and entorhinal cortex, globus pallidus, substantia nigra, and cerebellum. In contrast, chronic Δ9-THC treatment had no effect on GABAB-stimulated [35S]GTPγS binding. In membranes and brain sections, Δ9-THC was a partial agonist, stimulating [35S]GTPγS by only 20% of the level stimulated by WIN 55212-2 and inhibiting WIN 55212-2-stimulated [35S]GTPγS at high concentrations. Because the EC50 of WIN 55212-2-stimulated [35S]GTPγS binding and the KD of cannabinoid receptor binding were unchanged by chronic Δ9-THC treatment, the partial agonist actions of Δ9-THC did not produce the decrease in cannabinoid-stimulated [35S]GTPγS binding. These results suggest that profound desensitization of cannabinoid-activated signal transduction mechanisms occurs after chronic Δ9-THC treatment.

Effects of Chronic Treatment with Δ9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPγS Autoradiography in Rat Brain

Effects of Chronic Treatment with Δ⁹-Tetrahydrocannabinol on Cannabinoid-Stimulated [³⁵S]GTPγS Autoradiography in Rat Brain